alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 146.153 Concentrated orange juice for manufacturing. ( a ) Concentrated orange juice for manufacturing is the food that complies with the requirements of composition and label declaration of ingredients prescribed for frozen concentrated orange juice by § 146.146, except that it is either not frozen or is less concentrated, or both, and the oranges from which the juice is obtained may deviate from the standards for maturity in that they are below the minimum Brix and Brix-acid ratio for such oranges: *Provided,* however, that the concentration of orange juice soluble solids is not less than 20° Brix.
( b ) The name of the food is “Concentrated orange juice for manufacturing, ______” or “______ orange juice concentrate for manufacturing”, the blank being filled in with the figure showing the concentration of orange juice soluble solids in degrees Brix.
[42 FR 14433, Mar. 15, 1977, as amended at 58 FR 2881, Jan. 6, 1993]
[PORTIONS OF THIS EXHIBIT HAVE BEEN REDACTED PURSUANT TO A REQUEST FOR
CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION.]

                                  APPENDIX A-2

                                    PRODUCTS

Product Name:     AB ROLLER - AB-108

Product Description: Fitness Machine to exercise abdominal muscles

Projected Units Sold next 24 months: XXXXXX

Manufacturer:     CirTran-Asia

Sub-Manufacturer: XXXXXX

Marketing Partner Contact Info:     Tri-Star

Current Sale Price: $XXXXXX USD - CIRTRAN-ASIA

Current Cost to Manufacturer:       $XXXXXX

Total Tooling/Development Costs:    $ 10,000

Gross Profit Margin Per Unit - $XXXXXX

                         CirTran-Asia $XXXXXX USD
                               XXXXXX $XXXXXX USD

INSTANT ABS Stock Option Schedule

Upon full execution of this Agreement, Cirtran's parent CirTran Corporation will
issue the following options to purchase restricted common stock:

                           Charles Ho                500,000 shares

These initial options will vest and be exercisable only after Cirtran has sold
500,000 AB ROLLER units. The options will be exercisable at $.06 per share after
vesting. The options will expire and will no longer be exercisable on the date
one year after the date hereof.

In addition, for each whole multiple of 200,000 AB ROLLER units sold by Cirtran
during the first 24 months of this Agreement in excess of the initial 200,000
units, CirTran Corporation will grant Charles Ho an option to purchase 100,000
shares. Each such additional option will be exercisable for a period of 12
months at an exercise price equal to the fair market value of CirTran
Corporation stock on the date of grant (i.e. the mean between the high bid and
low asked prices for the stock for the date of determination).

As a condition to grant of the options, each option holder will be required to
make standard investment representations to CirTran Corporation.

[XXXXX - REDACTED PURSUANT TO REQUEST FOR CONFIDENTIAL TREATMENT AND FILED
SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.]
<PAGE>   1
                                  Exhibit 23.1


                    CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS



   
        As independent public accountants, we hereby consent to the
incorporation by reference in this registration statement of our report dated
February 17, 1998 incorporated by reference in Western Wireless Corporation's 
Form 10-K for the year ended December 31, 1997 and to all references to our 
firm included in this registration statement.


/s/  Arthur Andersen LLP
Seattle, Washington
March  27, 1998
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JAN-31-1998
<PERIOD-START>                             FEB-01-1997
<PERIOD-END>                               JAN-31-1998
<CASH>                                      28,010,000
<SECURITIES>                                         0
<RECEIVABLES>                                5,770,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            34,715,000
<PP&E>                                       4,911,000
<DEPRECIATION>                               2,797,000
<TOTAL-ASSETS>                              36,996,000
<CURRENT-LIABILITIES>                        8,058,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        75,000
<OTHER-SE>                                  28,863,000
<TOTAL-LIABILITY-AND-EQUITY>                36,996,000
<SALES>                                     28,223,000
<TOTAL-REVENUES>                            28,223,000
<CGS>                                        8,934,000
<TOTAL-COSTS>                               15,421,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              15,000
<INCOME-PRETAX>                                627,000
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            627,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   627,000
<EPS-PRIMARY>                                      .08
<EPS-DILUTED>                                      .08
        

</TABLE>
Editorial Note on Part 118
Editorial Note: Nomenclature changes to part 118 appear at 81 FR 49896, July 29, 2016.

§ 118.10 Recordkeeping requirements for the Salmonella Enteritidis (SE) prevention plan. ( a ) *Records:* You must maintain the following records documenting your SE prevention measures: ( 1 ) A written SE prevention plan required by § 118.4;
( 2 ) Documentation that pullets were “SE monitored” or were raised under “SE monitored” conditions, including environmental testing records for pullets, as required by § 118.4(a)(2);
( 3 ) Records documenting compliance with the SE prevention measures, as follows: ( i ) Biosecurity measures;
( ii ) Rodent and other pest control measures;
( iii ) Cleaning and disinfection procedures performed at depopulation, when applicable;
( iv ) Refrigeration requirements;
( v ) Environmental and egg sampling procedures, when applicable, performed under § 118.7;
( vi ) Results of SE testing, when applicable, performed under § 118.8 as required in §§ 118.4(a)(2), 118.5, and 118.6;
( vii ) Diversion of eggs, if applicable, as required in § 118.6; and
( viii ) Eggs at a particular farm being given a treatment as defined in § 118.3, if you are a producer complying with the requirements of this section as described in § 118.1(a)(2).
( 4 ) Records of review and of modifications of the SE prevention plan and corrective actions taken.
( b ) *General requirements for records maintained by shell egg producers.* All records required by § 118.10(a) must include: ( 1 ) Your name and the location of your farm,
( 2 ) The date and time of the activity that the record reflects,
( 3 ) The signature or initials of the person performing the operation or creating the record. The written SE prevention plan must be dated and carry the signature(s) (not initials) of the person(s) who administers the plan as described in § 118.9, and
( 4 ) Data and information reflecting compliance activities must be entered on records at the time the activity is performed or observed, and the records must contain the actual values observed, if applicable.
( c ) *Length of time records must be retained.* You must retain all records required by this part at your place of business, unless stored offsite under § 118.10(d), for 1 year after the flock to which they pertain has been taken permanently out of production.
( d ) *Offsite storage of records.* You may store the records required by this part, except for the written SE prevention plan, offsite. You must be able to retrieve and provide the records at your place of business within 24 hours of request for official review. Electronic records are considered to be onsite if they are accessible from an onsite location.
( e ) *Official review of records.* You must have all records required by this part available for official review and copying at reasonable times.
( f ) *Public disclosure of records.* Records required by this part are subject to the disclosure requirements under part 20 of this chapter.
[No. 40056-8-I.

Division One.

January 26, 1998.]

#### The State of Washington, *Respondent,*v. Arraick Porter, *Appellant.*

Appeal from a judgment of the Superior Court for King County, No. 96-1-05496-4, Michael Hayden, J., entered January 6, 1997. *Affirmed*by unpublished per curiam opinion.
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 26 Introduced in House (IH)]

<DOC>

115th CONGRESS
  1st Session
H. RES. 26

     Expressing the sense of the House of Representatives that the 
   provisions of the Patient Protection and Affordable Care Act that 
  restored the original black lung benefits eligibility requirements 
      should not be reduced but should be preserved and protected.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 5, 2017

Mr. Jenkins of West Virginia (for himself, Mr. Rogers of Kentucky, Mr. 
McKinley, Mr. Griffith, and Mr. Mooney of West Virginia) submitted the 
following resolution; which was referred to the Committee on Education 
                           and the Workforce

_______________________________________________________________________

                               RESOLUTION

 
     Expressing the sense of the House of Representatives that the 
   provisions of the Patient Protection and Affordable Care Act that 
  restored the original black lung benefits eligibility requirements 
      should not be reduced but should be preserved and protected.

Whereas men and women who spend their lives mining coal deserve the black lung 
        benefits afforded them through the Black Lung Benefits Act;
Whereas these critical benefits are important for thousands of men and women 
        across the United States;
Whereas, since 1969, black lung benefits have been guaranteed by the Federal 
        Government and have provided assistance for miners and their widows;
Whereas, in 1981, the Black Lung Benefits Act was amended tightening eligibility 
        requirements and eliminating two provisions regarding the entitlement 
        benefits of coal minors and survivors alike;
Whereas the Black Lung Benefits Act was amended by the Patient Protection and 
        Affordable Care Act to restore provisions similar to those in the 
        original Black Lung Benefits Act, providing equity for certain eligible 
        survivors;
Whereas these restored black lung benefits are critical for the widows and 
        widowers of miners;
Whereas the leadership of the House of Representatives and the Senate have 
        indicated that Congress will act to repeal the Patient Protection and 
        Affordable Care Act in the 115th Congress; and
Whereas President-elect Donald Trump has indicated that he would sign a repeal 
        of the Patient Protection and Affordable Care Act: Now, therefore, be it
    Resolved, That it is the sense of the House of Representatives that 
in the event that Congress drafts provisions to amend or repeal the 
Patient Protection and Affordable Care Act, the provisions of such Act 
that restored the original black lung benefits eligibility requirements 
should not be reduced but should be preserved and protected.
                                 <all>
```
1 / FDA Consumer Health Infor mat ion / U. S. Food and Dr ug Adminis t r at ion JUNE 2010

Consumer Health Information

www.fda.gov/consumer

The product, Magic Power Coffee, 

contains a potentially dangerous 

ingredient. The product is sold in a 

two-serving box as well as in a carton 

that contains six two-serving boxes.

FDA’s lab analysis determined that 

Magic Power Coffee contains a chemical similar to the active ingredient in 

the prescription drug Viagra to treat 

erectile dysfunction. The chemical 

may interact with prescription drugs 

known as nitrates, including nitroglycerin, and cause dangerously low 

Magic Power Coffee:

POTENTIALLY

DANGEROUS

Not Magical

C

onsumers should not use an instant coffee being sold 

online as a dietary supplement for sexual enhancement, 

warns the Food and Drug Administration (FDA).

Find this and other Consumer 

Updates at www.fda.gov/

ForConsumers/ConsumerUpdates

 Sign up for free e-mail 

subscriptions at www.fda.gov/

consumer/consumerenews.html

Photo of actual product.

blood pressure.

Although Magic Power Coffee is 

labeled as an “all natural dietary supplement,” it can cause serious harm. 

Sexual enhancement products that 

claim to work as well as prescription 

products are likely to expose consumers to unpredictable risks and 

the potential for injury or even death.

Advice for Consumers

1. Stop using Magic Power Coffee 

immediately.

2. If you have experienced any bad 

side effects from Magic Power Coffee or any sexual enhancement 

products, talk to a health care professional.

3. Report any side effects with the 

use of any sexual enhancement 

products to FDA’s MedWatch 

Adverse Event Reporting Program 

either online, by regular mail, by 

fax, or by phone.

• Online (www.fda.gov/MedWatch/)

• Regular Mail: Use postage-paid, 

pre-addressed FDA form 3500 

(www.accessdata.fda.gov/scripts/

medwatch/)

• Fax: 1-800-FDA-0178

• Phone: 1-800-332-1088
## SUPREME COURT OF THE STATE OF NEW YORK 

## Appellate Division, Fourth Judicial Department

**1376 KA 13-01476**  PRESENT: SCUDDER, P.J., SMITH, CARNI, LINDLEY, AND SCONIERS, JJ.

THE PEOPLE OF THE STATE OF NEW YORK, RESPONDENT,

V MEMORANDUM AND ORDER
RICHARD A. SCHILLAWSKI, DEFENDANT-APPELLANT. (APPEAL NO. 2.)

CURRIER LAW FIRM, P.C., AUBURN (REBECCA CURRIER OF COUNSEL), FOR DEFENDANT-APPELLANT.
JON E. BUDELMANN, DISTRICT ATTORNEY, AUBURN (NATHAN J. GARLAND OF COUNSEL), FOR RESPONDENT.

Appeal from a judgment of the Cayuga County Court (Thomas G. Leone, J.), rendered July 18, 2013. The judgment convicted defendant, upon his plea of guilty, of grand larceny in the fourth degree.
It is hereby ORDERED that the judgment so appealed from is unanimously affirmed.

Same Memorandum as in People v Schillawski ([appeal No. 1] ___ AD3d ___ [Jan. 2, 2015]).

Entered: January 2, 2015 Frances E. Cafarell Clerk of the Court
I 

118TH CONGRESS 

2D SESSION H. R. 7100 

To amend title 38, United States Code, to clarify the organization of the 

Office of Survivors Assistance of the Department of Veterans Affairs. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 29, 2024 

Mr. CISCOMANI (for himself and Mr. BOST) introduced the following bill; 

which was referred to the Committee on Veterans’ Affairs 

A BILL 

To amend title 38, United States Code, to clarify the organization of the Office of Survivors Assistance of the Department of Veterans Affairs. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Prioritizing Veterans’ 

5 Survivors Act’’. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7100 IH

1 SEC. 2. CLARIFICATION OF ORGANIZATION OF THE OFFICE 

2 OF SURVIVORS ASSISTANCE OF THE DEPART3 MENT OF VETERANS AFFAIRS. 

4 Section 321(a) of title 38, United States Code, is 

5 amended by striking ‘‘in the Department’’ and inserting 

6 ‘‘in the Office of the Secretary’’. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
Exhibit
4.138


 


Equity
Transfer Agreement


Shanghai
Meining Computer Software Co., Ltd.


 


This
Agreement is jointly made and executed in the Company’s conference room on January 12, 2016 by and between the following
parties:


 


Transferor:
Beijing Fuhua Innovation Technology Development Co., Ltd. ("CFO Fuhua") (hereinafter referred to as “Party A”);


 


Transferee:
Shanghai Fenxin Information Technology Co., Ltd. (hereinafter referred to as “Party B”)


 


Tibet
Fortune Network Technology Co., Ltd. (hereinafter referred to as “Party C”)


 


Shanghai
Meining Computer Software Co., Ltd. (hereinafter referred to as the “Subject Company”) owns registered capital of
RMB11,646,300, which is fully contributed by Party A.


 


The
parties agree as follows through negotiation and pursuant to the provisions of relevant laws and regulations:


 


Article
1 Subject Matter and Price of Equity Transfer


 


1       Party
A transfers 90% of equities in the Subject Company to the new shareholder, Party B, at a price of RMB72,000,000. Party A transfers
10% of equities in the Subject Company to the new shareholder, Party C, at a price of RMB8,000,000.


 


2       Other
rights adhere to the equities will be transferred together with the equities upon the equity transfer.


 


3       The
Transferee shall pay the transfer price off regarding the equity transfer to the Transferor within fifteen (15) days upon completion
of the changes in registration thereof.


 


Article
2 Undertaking and Warrants


 


Party
A warrants that it owns the legal title of, as well as complete and effective right of disposal of such equities to be transferred
to Party B under Article 1 hereof. Party A warrants that no pledge or mortgage or other encumbrance is set on the contemplated
equities hereof and thereby it shall be free from any third person’s claim thereof.


 


Article
3 Liabilities for Breach


 


Party
B undertakes to fully pay off the payment regarding the equity transfer within the agreed timeframe; otherwise, it shall be deemed
as a breach of the Agreement and Party B shall pay a penalty at the rate of 0.3 percent per day.


 


Article
4 Resolution of Dispute


 


This
Agreement is governed and construed by the relevant laws of the People’s Republic of China. Any disputes resulting from
or in connection with this Agreement shall be resolved through friendly negotiation by the Parties hereto, otherwise, such dispute
shall be submitted directly before a competent people’s court.


 


Article
5 Miscellaneous


 


		1.	This
                                         Agreement shall be made in quintuplicate, four of which shall be held by the Parties
                                         hereto and the Subject Company and the forth shall be submitted to the competent bureau
                                         of industry for the purpose of relevant procedures.



 


This
Agreement shall come into effect upon execution by each Party.


 


	Party
    A: (Signature)	Party
    B: (Signature)
	 	 
	Party
    C: (Signature)	Date:
Editorial Note on Part 184
Editorial Note: Nomenclature changes to part 184 appear at 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 69 FR 13717, Mar. 24, 2004; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; and 81 FR 49897, July 29, 2016.

§ 184.1009 Adipic acid. ( a ) Adipic acid (C6H10O4, CAS Reg. No. 00124-04-9) is also known as 1,4-butanedicarboxylic acid or hexane-dioic acid. It is prepared by nitric acid oxidation of cyclohexanol or cyclohexanone or a mixture of the two.
( b ) The ingredient meets the specifications of the Food Chemicals Codex, 3d Ed. (1981), p. 11, which is incorporated by reference (Copies are available from the National Academy Press, 2101 Constitution Ave., NW., Washington, DC 20418, or available for inspection at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: *http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html .*), and the following additional specifications: ( 1 ) The adipic acid is converted to its corresponding amide. The amide is purified by recrystallization from water or aqueous ethanol. The melting range of the amide is 219° to 220 °C.
( 2 ) The adipic acid is converted to its corresponding *bis-p-p-*bromophenacyl ester. The ester is purified by recrystallization from ethanol. The melting range of the ester is 153° to 154 °C.
( c ) The ingredient is used as a flavoring agent as defined in § 170.3(o)(12) of this chapter; leavening agent as defined in § 170.3(o)(17) of this chapter; and pH control agent as defined in § 170.3(o)(23) of this chapter.
( d ) The ingredient is used in foods at levels not to exceed current good manufacturing practice in accordance with § 184.1(b)(1). Current good manufacturing practice results in maximum levels, as served, of 0.05 percent for baked goods as defined in § 170.3(n)(1) of this chapter; 0.005 percent for nonalcoholic beverages as defined in § 170.3(n)(3) of this chapter; 5.0 percent for condiments and relishes as defined in § 170.3(n)(8) of this chapter; 0.45 percent for dairy product analogs as defined in § 170.3(n)(10) of this chapter; 0.3 percent for fats and oil as defined in § 170.3(n)(12) of this chapter; 0.0004 percent for frozen dairy desserts as defined in § 170.3(n)(20) of this chapter; 0.55 percent for gelatin and puddings as defined in § 170.3(n)(22) of this chapter; 0.1 percent for gravies as defined in § 170.3(n)(24) of this chapter; 0.3 percent for meat products as defined in § 170.3(n)(29) of this chapter; 1.3 percent for snack foods as defined in § 170.3(n)(37) of this chapter; and 0.02 percent or less for all other food categories.
( e ) Prior sanctions for adipic acid different from the uses established in this section do not exist or have been waived.
[47 FR 27810, June 25, 1982]